Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by 12CenterLineon Apr 19, 2019 9:08pm
43 Views
Post# 29650107

RE:RE:RE:RE:RE:RE:Wow

RE:RE:RE:RE:RE:RE:WowWell those are you feelings. Citing articles from the Fool doesn't make a strong argument. They are not a reputable source. So you say wrong without any credible information to back it up. Please learn how to have a proper debate.


Homestretch4me wrote: MOLSON PASSED

https://www.equities.com/news/the-reason-hexo-corp-beat-out-aphria-and-aurora-for-a-deal-with-molson-coors
Homestretch4me wrote: COKE PASSED

https://www.fool.ca/2018/11/02/did-aurora-cannabis-incs-tsxacb-beverage-deal-fall-through/
12CenterLine wrote: Why go you think that the companies passed on aurora and not aurora passing on them? The are growing their business in a much different way from their peers. Personally I think it will pay off in the long run. People need to remember that companies execute their own growth strategy. If you don't like it then don't invest with the company. It's that easy!


Homestretch4me wrote: That's exactly my point. Canopy's management was able to broker a 5 billion dollar deal on their own while Aurora's management has had to ask for help. It is tough to get a partner when you have had reckless dilution and have over a billion shares. Let's see what Nelson can broker that your management team couldn't. Have you asked yourself why other smaller companies like Hexo and Cronos were able to get partnerships/deals? Why did a lot of fortune 500 companies pass on Aurora?
mozzarella wrote: $Nelson Petlz and his connections$ is who you need to chat with not a message board concerning your silly antics .... you have no ideal do you? 


Homestretch4me wrote:
320,000,000 shares is what it would cost Aurora to do a deal like Canopy just did. You guys are now stuck spinning your wheels because you have no cash.

 

 

 

 




Bullboard Posts